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Abstract
Background. Poor medication compliance and control may diminish the effectiveness of the prescribed 
therapy and might threaten the patient’s health. It is a substantial issue in palliative care as almost one-third 
of patients fail to conform to their therapeutic regimens. Non-compliance may lead to more admissions, 
longer stay at hospital and more short-term and long-term morbidity and mortality. 
Purpose. Tools have to be implemented to limit non-compliance and ensure that patients are able, with 
encouragement and supervision, to monitor their treatment progress. Medication card is an excellent 
candidate, since it retains the essential information of the patient, doctor and the prescribed drug, and 
it also provides convenience, as patients are able to check their progress in real-time, and keep an eye on 
potential side effects and complications. This paper describes a model created of patient-version of steroids 
medication card that fulfill the abovementioned goal and provide this service to the palliative care patients. 
Methods. The research was guided and supervised by palliative care specialists and nurses, and I appro-
ached multiple patients to calibrate the language and structure for simplicity and clarity. Furthermore, 
I reviewed official medication card forms produced by major hospices in order to configure the appropriate 
composition and format of the card. This work is expected to facilitate control and monitoring of steroid 
regimens palliative care settings.
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Introduction
Palliative care is the branch of medicine that spe-
cialises in managing people with serious and terminal 
illnesses, and their families, by providing relief from 
physical and psychological symptoms, primarily pain 
and stress [1]. The main objective of care is to im-
prove their quality of life and preserve their dignity 
as much as possible [2]. During therapeutic manage-
ment, palliative care practitioners prescribe a myriad 
of medications that are known to have serious side 
effects, such as opioids, steroids and anticonvul-
sants. It is worth noting that palliative care patients 
typically have advanced diseases and their health 
conditions are usually much poorer than the majority 
of patients. Consequently, monitoring such clients for 
potential adverse effects and complications as well as 
keeping a tight and attentive control on the dosage 
and compliance are imperative and essential role in 
being a palliative care practitioner. It is evidently not 
sufficient to rely only on observable physical and 
mental deviations or counting solely on the patient’s 
self-reporting. That is because side effects might not 
be plainly obvious to palliative care practitioners and 
patients alike, and on the other hand, patients are 
certainly prone to forget and neglect such changes, 
or might interpret them as an expected progression 
of the disease. Therefore, a tool devised to ensure 
Medycyna Paliatywna w Praktyce 2016, vol 10, no 4
www.journals.viamedica.pl/medycyna_paliatywna_w_praktyce150
king at the palliative care services in the Royal Brisbane 
Hospital. This card has to be written in lay-language, 
as it will be chiefly directed to and managed by the 
patients, and should contain their personal informa-
tion, exhaustive details about the prescribed drug, 
and the prescribing doctor’s contact information. 
I worked under the supervision and advice of the 
palliative care specialists and nurses. They offered 
me a considerable help to generate an appropriate 
structure and plan starting from the initial scheme as 
seen in the appendix (Fig.1).
Material and methods
The steroid medication card that was devised here 
has been initially inspired from a doctor-oriented Ste-
roid Proforma acquired from the Princess Alexandra 
hospital, which was produced in 2008 by a coalition 
of hospices and palliative care providers in the Uni-
ted Kingdom (Fig. 2) and also a Steroid Replacement 
handout produced by the Imperial College Healthcare 
NHS Trust (Fig. 3). Next, as the project progressed, 
I had multiple meetings with the director of the 
palliative care services at the Royal Brisbane hospital 
Dr. Carol Douglas, and the palliative care specialist 
Dr. Alison Kearney, as well as discussions with the 
rest of the team members, including palliative care 
nurses and medical trainees. I also consulted with 
some of the patients whom the services oversee 
to gauge the clarity and simplicity of the language 
and structure. Unlike the two documents that were 
mentioned in the beginning of this section, which 
have markedly descriptive and instructive technical 
structure, my design is much more ‘layman-friendly’ 
patients and practitioners’ attention and vigilance 
towards adverse effect and complications has to be 
implemented in such settings. Medication cards, that 
contain essential information about the patient and 
the prescribed drug, can be very helpful here, espe-
cially for those on a long-term course of potentially 
harmful classes of drugs, which steroids is an obvious 
example  in the domain of palliative care [3]. Steroids 
or corticosteroids are used commonly in palliative care 
to alleviate specific and non-specific symptoms related 
to diseases like advanced malignancies. A few types 
of corticosteroids are used in palliative care, namely 
Dexamethasone and Prednisolone, and both have 
variable efficacy. The indications for corticosteroids 
use include, for example, spinal cord compression and 
elevated intracranial pressure as well as pain, nausea 
and malaise [4]. The widespread and prolonged use 
of steroids has inevitably led to an increase in the 
prevalence and impact of its side effects, both major 
and minor. These include disruption of innate hormo-
ne secretion in the hypothalamus-pituitary-adrenal 
(HPA) axis, as well as sodium and water retention, 
immunosuppression, edema in the extremities, psy-
chological changes, hypertension, hyperglycemia, and 
skin changes. Furthermore, corticosteroids have con-
traindications with numerous drugs that are prescri-
bed frequently, such as particular classes of antivirals 
and antibiotics. They should also be avoided, or at 
least reconsidered, in a number of medical conditions, 
such as diabetes mellitus and active infection, as they 
will most likely aggravate the disease symptoms and 
signs in the affected person [5]. 
Following the aforementioned facts, I started wor-
king on a steroid medication card model while wor-
Figure 1. The initial scheme of the project
www.journals.viamedica.pl/medycyna_paliatywna_w_praktyce 151
Muath Alduhishy, A proposed steroid card model for palliative care patients
Figure 2. Steroid Proforma produced by the Princess Alice Hospice, Harris Hospice Care, Guy’s and St Thomas’s 
Foundation and St. Christopher’s Hospice in the United Kingdom
as it was aimed to patients so they can participate in 
the drug monitoring process. At first, the initial draft 
(Fig. 4) has the title “Steroid Card for Palliative Care”, 
to elucidate the intended purpose, and the caveat 
“Complete once for each course”. It consists of one 
page that has spaces to be filled pertaining to the 
prescribed drug specifics, namely its type, starting 
dosage, frequency, route, indications and whether 
it has been used before or not. In addition, a space 
was left for the course plan including when to wean, 
and a section illustrating the main contraindicated 
drugs and conditions has been added. The card also 
asks technical questions directed to the doctor about 
further clinical details and precautions. Later on, the 
following issues have been highlighted: 1) Dexame-
thasone and Prednisolone are the only corticosteroids 
available for palliative care patients in the hospital. 
2) Drug frequency should be left as blank to give 
more freedom. 3) A space should be provided for the 
prescribing doctor information. 4) Clinical instructions 
should be avoided since it is directed to patients not 
doctors. 5) Writing spaces are too small and thus 
must be expanded. 6) The major side effects should 
be included.
Unsurprisingly, when I consulted with a number 
of palliative care patients they found the first draft to 
be difficult to read and use.
Next, the steroid card was amended and impro-
ved based on the previous suggestions along with 
a redesigned and enhanced layout. Accordingly, with 
the assistance of the literature, the major side effects, 
specifically those that present to patients as observa-
ble symptoms, are highlighted in a simple language 
[5, 6]. The idea is to alert patients so they can contact 
their doctors when such symptoms manifest. Further-
more, a review table was added on the back of the 
paper to record the details of every drug review. It 
encompasses the date of review, response, toxicity, 
new dose, date of the next review and the reviewing 
doctor signature. A warning was also annexed to 
emphesise on patients not to stop taking steroids 
without consulting their doctors.
Discussion
The final work was completed as pictured in Figu-
re 5. Given the importance of the subject, the design’s 
schema and language were purposefully simplistic in 
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Figure 3. Steroid Replacement handout produced by the Imperial College 
Healthcare NHS Trust
order to be visually clear and undistracting. The medica-
tion card consists of two pages so it can be printed into 
a one double-sided sheet of paper making it convenient 
and easier to carry around. There is a designated space 
in the upper left corner of the first page to affix the pa-
tient label, which has their basic information. However, 
if the label was not available, the patient can fill his or 
her own information, specifically the name, number, 
dates of birth and address. Next, the right side of the 
first half of the page is assigned to the essential drug 
details; starting date, type, initial dose, frequency per 
day, where it was started and the prescribing doctor’s 
contact details. Then, a large table was drawn with 
this warning on top of it “DON’T STOP taking steroids 
without consulting with your doctor”. Underneath it, 
there is a space left to write down the indications for 
taking the medication, and another space to answer 
the question “Have you used Steroids before?”. If the 
answer was yes, then more questions have to be an-
swered: Why? What type? For how long? and How was 
the response?. Next, the drug course details have to 
be written including the date of first review, duration 
of course and indications for stopping and weaning. 
Afterward, lists of the main medical conditions and 
medications that are contraindicated with steroids, and 
also the major symptoms of adverse effects were char-
ted with the declaration: Please inform your doctor if 
you are having/taking/experiencing the listed items. At 
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Figure 4. First draft of the steroid card with the proposed comments and notes
Figure 5. The final form of the steroid card for palliative care patients
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the end of the first page, the name of doctor who will 
monitor the therapy regimen after discharge has to 
be recorded with their contact details. On the second 
page that resides in the backside, a large segmented 
table is drawn to record the progress of therapy by 
documenting each drug review including the date, re-
sponse, toxicity, adjusted dose, date of the next review, 
and the doctor signature.
Conclusions
To conclude, the product of the project conducted 
here is a steroid card developed under the supervision 
of experienced palliative care specialists as well as 
lay-people’s validation of the clarity of its language and 
structure. It encompasses the necessary information 
to verify the identity of the patient and their doctor 
along with thorough details of the medication and its 
therapeutic course. The steroid card offers an excellent 
tool to monitor patients’ compliance and detect if they 
start to develop any of the major side effects or com-
plications. However, this is not the end of the line. The 
next step is to conduct a pilot study on a set of patients, 
while using another set who did not receive this card 
as controls, and see if this steroid card aids significantly 
in the patient adherence to the therapy regimen and 
whether it provides better control and vigilance to side 
effects and complications. The outcome of the study 
will confirm the value of such a tool, and it will guide 
future decision on using medication cards in palliative 
care, or even other branches of medical practice.
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